Javier Ibero

Mr. Javier Ibero

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
GGGuglielmo Gallone
Guglielmo Gallone
JIJavier Ibero
Javier Ibero
AMAndrew Morley‐Smith
Andrew Morley‐Smith
MVMaria Monteagudo Vela
Maria Monteagudo Vela
FFFrancesca Fiorelli
Francesca Fiorelli
FGFernando Riesgo Gil
Fernando Riesgo Gil
Background: We evaluated the potential benefits of renin‐angiotensin‐aldosterone system inhibitors (RAASi) in patients with left ventricular assist device support. Methods and Results: A total of 165 consecutive patients undergoing left ventricular assist device implant and alive at 6‐month on support were studied. RAASi status after 6‐month visit along with clinical reasons for nonprescription/uptitration were retrospectively assessed. The primary outcome was a composite of heart failure hospitalization or cardiovascular death between 6 and 24 months after left ventricular assist device implant. Remodeling and hemodynamic outcomes were explored by studying the association of RAASi new prescription/uptitration versus unmodified therapy at 6‐month visit with the change in echocardiographic parameters and hemodynamics between 6 and 18 months. After the 6‐month visit, 76% of patients were on RAASi. Patients' characteristics among those receiving and not receiving RAASi were mostly similar. Of 85 (52%) patients without RAASi new prescription/uptitration at 6‐month visit, 62% had no apparent clinical reason. RAASi were independently associated with the primary outcome (adjusted hazard ratio, 0.31 [95% CI, 0.16–0.69]). The baseline rates of optimal echocardiographic profile (neutral interventricular septum, mitral regurgitation less than mild, and aortic valve opening) and hemodynamic profile (cardiac index ≥2.2 L/min per m 2 , wedge pressure <18 mm Hg, and right atrial pressure <12 mm Hg) were similar between groups. At 18 months, patients receiving RAASi new prescription/uptitration at 6 months had higher rates of optimal hemodynamic profile (57.5% versus 37.0%; P =0.032) and trends for higher rates of optimal echocardiographic profile (39.6% versus 22.9%; P =0.055) compared with patients with 6‐month unmodified therapy. Optimal 18‐month hemodynamic and echocardiographic profiles were associated with the primary outcome (log‐rank=0.022 and log‐rank=0.035, respectively). Conclusions: RAASi are associated with improved outcomes and improved hemodynamics among mechanically unloaded patients.

21 October 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
GGGuglielmo Gallone
Guglielmo Gallone
LBLuca Baldetti
Luca Baldetti
MKMailen Konicoff
Mailen Konicoff
JIJavier Ibero
Javier Ibero
AMAlba Maestro‐Benedicto
Alba Maestro‐Benedicto
FGFernando Riesgo Gil
Fernando Riesgo Gil
Background: Durable left ventricular assist device (dLVAD) physiology predisposes to right heart failure (RHF) and aortic insufficiency (AI), recently labeled hemodynamic‐related events (HDREs). We sought to validate the recently proposed dLVAD Hemodynamic Classification System for HDREs. Methods: RHF and AI HDREs were adjudicated, staged, and phenotyped on the basis of the Hemodynamic Classification System assessed at 6 months after dLVAD implantation. The primary outcome was a composite of HF hospitalization or cardiovascular death between 6 and 24 months after dLVAD implantation. Results: Among 183 qualifying consecutive patients with 6‐month assessments, RHF HDRE was adjudicated in all cases and AI HDRE in 161 (88.0%). Overall, 53 (29.0%) patients developed an RHF HDRE and 26 (16.0%) an AI HDRE (phenotypes: 39 isolated RHF, 15 isolated AI, 11 combined RHF–AI, 3 not adjudicated). At pre‐dLVAD assessment, age and pulmonary artery pulsatility index were independently associated with RHF HDRE and pre‐dLVAD AI and systolic pulmonary artery pressure with AI HDRE. RHF HDRE (adjusted hazard ratio [HR], 2.69 [95% CI, 1.14–6.34]; P =0.024), AI HDRE (adjusted HR, 4.21 [95% CI, 1.70–10.40]; P =0.002), and HDRE phenotypes (isolated RHF/AI HDRE versus no HDRE: adjusted HR, 2.80 [95% CI, 1.03–7.62]; P =0.044; combined RHF/AI HDRE versus no HDRE: adjusted HR, 4.53 [95% CI, 1.33–15.35]; P =0.015) were associated with the primary outcome. A graded increase in primary outcome was observed with increasing RHF and AI stages. Conclusions: We validated the dLVAD Hemodynamic Classification System for HDREs as a valuable tool to identify pathophysiological and clinical clusters of patients, linking it with significant prognostic implications. Its adoption may pave the way for targeted strategies aimed at mitigating HDREs and enhancing the long‐term success of dLVAD support.

6 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
JIJavier Ibero
Javier Ibero
IGIgnacio García-Bolao
Ignacio García-Bolao
GBGabriel Ballesteros
Gabriel Ballesteros
PRPablo Ramos
Pablo Ramos
RARamon Albarran
Ramon Albarran
IDInes Diaz-Dorronsoro
Ines Diaz-Dorronsoro
Background: Atrial fibrosis is a key contributor to atrial cardiomyopathy and can be assessed invasively using mean left atrial voltage (MLAV) from electroanatomical mapping. However, the invasive nature of this procedure limits its clinical applicability. Machine learning (ML), particularly regression tree-based models, may offer a non-invasive approach for predicting MLAV using clinical and echocardiographic data, improving non-invasive atrial fibrosis characterisation beyond current dichotomous classifications. Methods: We prospectively included and followed 113 patients with paroxysmal or persistent atrial fibrillation (AF) undergoing pulmonary vein isolation (PVI) with ultra-high-density voltage mapping (uHDvM), from whom MLAV was estimated. Standardised two-dimensional transthoracic echocardiography was performed before ablation, and clinical and echocardiographic variables were analysed. A regression tree model was constructed using the Classification and Regression Trees—CART-algorithm to identify key predictors of MLAV. Results: The regression tree model exhibited moderate predictive accuracy (R2 = 0.63; 95% CI: 0.55–0.71; root mean squared error = 0.90; 95% CI: 0.82–0.98), with indexed minimum LA volume and passive emptying fraction emerging as the most influential variables. No significant differences in AF recurrence-free survival were found among MLAV tertiles or model-based generated groups (log-rank p = 0.319 and p = 0.126, respectively). Conclusions: We present a novel ML-based regression tree model for non-invasive prediction of MLAV, identifying minimum LA volume and passive emptying fraction as the most significant predictors. This model offers an accessible, non-invasive tool for refining atrial cardiomyopathy characterisation by reflecting the fibrotic substrate as a continuum, a crucial advancement over existing dichotomous approaches to guide tailored therapeutic strategies.

26 June 2026 in European Journal of Radiology
Verified
Journal Article
Open access
LMLeire Moriones
Leire Moriones
Pablo LamataPablo Lamata
Pablo Lamata
BEBlas Echebarria
Blas Echebarria
DLDavid Laroze
David Laroze
JIJavier Ibero
Javier Ibero
JBJean Bragard
Jean Bragard
Atrial fibrillation (AF) involves heterogeneous remodelling of the left atrium (LA), making accurate geometric quantification clinically relevant. CT is the reference standard for anatomical assessment, whereas electroanatomical mapping (EAM) provides intraprocedural reconstruction with electrophysiological information. However, agreement between both modalities remains incompletely characterized. We retrospectively analyzed 211 patients undergoing first-time catheter ablation with pre-procedural CT imaging. LA volume, surface area, and sphericity were derived from CT and EAM. A common ellipsoidal model was fitted to both datasets for comparison via semi-axes (a, b, c). Agreement was assessed using Pearson correlation and Bland-Altman analysis. Geometric differences were quantified using RMS radial differences and Dice similarity on both original meshes and ellipsoidal approximations. EAM correlated with CT for volume (r = 0.58), area (r = 0.56), and sphericity (r = 0.49) (all p < 0.001). Bland-Altman analysis demonstrated systematic overestimation of volume (11.1 cm3, 13.2 %) and surface area (8.9 cm2, 9.6 %), with slight underestimation of sphericity (-0.01). RMS radial differences were higher for original meshes than ellipsoidal approximations (0.14 vs 0.08), while Dice similarity was higher for ellipsoids than original geometries (0.89 IQR [0.85-0.91] vs 0.81 IQR [0.77-0.83]). EAM provides a rapid intraprocedural approximation of left atrial geometry but does not fully reproduce CT-derived anatomy. While global shape is partially preserved, systematic scale differences and local discrepancies persist, supporting its role as a complementary rather than substitute modality.